Medovate
Currently, there is no content with this tag.
Loading...
Medovate signs distributor agreement with Temena for "game-changing" SAFIRA technology
Medovate has concluded a distribution agreement with Germany-head quartered Temena providing the distribution rights for SAFIRA (SAFer Injection for Regional Anaesthesia) across Germany, France, Italy and Spain Read more
Medovate and JEB Technologies combine to drive innovation
Medovate and JEB Technologies have become part of the same group structure that will integrate their management, skill sets and expertise in a bid to drive greater collaboration, innovation and growth in the sector. Read more
Medovate and Fannin strike distribution deal for SAFIRA in Ireland
Medovate, the Cambridge-based medical device development company, has concluded a distribution agreement with Fannin Limited giving the Dublin-based company distribution rights for SAFIRA (SAFer Injection for Regional Anaesthesia) across Ireland. Read more
Positive reaction from medtech as UK rejoins Horizon
The medical technology industry in the UK has largely welcomed the move from the UK government to rejoin the Horizon Programme as an associate member. Read more
Medovate's SAFIRA officially launches in Singapore
Medovate – a medical device development company – has announced that the SAFIRA (SAFer Injection for Regional Anaesthesia) Palm Operator has officially been launched in the Singapore market having secured approval from the Singapore HSA. Read more
Medovate's SAFIRA device receives Vizient Innovative Technology contract
Medovate announced its SAFIRA (SAFer injection for Regional Anaesthesia) has received an Innovative Technology contract from Vizient, a US’s member-driven healthcare performance improvement company. Read more
Medovate signs first distributor agreement in the veterinary field
Medovate has signed a distributor agreement with 20/20 Imaging, a division of Konica Minolta Healthcare Americas to make its technology for regional anaesthesia available across the veterinary market in the US. Read more
Johnson & Johnson MedTech & Barts Health NHS headline Day Two
Group Content Manager Ian Bolland previews a couple of the highlights of the Day 2 Med-Tech Innovation Expo conference programme, with Johnson & Johnson MedTech headlining on the main stage along with Barts Health NHS Trust. Read more
Medovate's SAFIRA device approved in Saudi Arabia
Medovate and its Saudi Arabia based distributor AKSIA Healthcare have secured SFDA (Saudi Food and Drug Authority) Approval for the SAFIRA (SAFer Injection for Regional Anaesthesia) device. Read more
Medovate and Qualitech strike deal to support SAFIRA roll out
Medovate, a Cambridge based manufacturer of medical technologies created from within the NHS, has concluded an agreement with Qualitech Healthcare to support the roll out of the innovative SAFIRA system to hospitals in the UK. Read more
Medovate appoints Frank Collins as chair
Medovate – a manufacturer of medical technologies created from within the NHS and part of Mercia Venture’s portfolio of companies – has appointed Frank Collins O.B.E as the company’s new chair with effect from December 2022. Read more
Securing 40 patents in four years: Navigating the IP landscape
Robert Donald, innovation and licensing officer at Medovate explains how the company navigates the IP landscape having secured 40 patents in four years. Read more
Medovate awarded new group purchasing agreement for SAFIRA
Medovate Ltd – a UK medical device development company based in Cambridge – has been awarded a new group purchasing agreement with Premier for its regional anaesthesia system SAFIRA (SAFer Injection for Regional Anaesthesia). Read more
Medovate's SAFIRA added to Vizient GPO contract
Medovate’s regional anaesthesia technology SAFIRA (SAFer Injection for Regional Anaesthesia) has been added to the Vizient Group Purchasing Organisation (GPO) contract alongside the Konica Minolta SONIMAGE HS2 Ultrasound System. Read more
Medovate secures approval for SAFIRA in Singapore
Medovate and its Singapore-based distributor Bluestone Corporation Pte have secured Singapore’s Health Sciences Authority (HSA) approval for the SAFIRA (SAFer Injection for Regional Anaesthesia) system. Read more
Medovate named 'Medtech Company of the Year'
Medovate has been awarded ‘Medtech Company of the Year’ at the Cambridge Independent Science and Technology Awards for 2022. Read more
Medovate strikes distribution deal for SAFIRA device in Middle East
UK-based Medovate, a medical device development company, has announced an agreement with AKSIA Healthcare FZC to distribute its SAFIRA (SAFer Injection for Regional Anaesthesia) product range in Saudi Arabia, the UAE and Bahrain. Read more
Medovate joins ABHI US Accelerator for second year running
Medovate is joining the Association of British HealthTech Industries (ABHI) US Accelerator 2022 cohort and is participating in the programme for a second year running. Read more
Medovate strikes deal with Mercury Medical for whole U.S. distribution
Medovate, a UK based medical device development company, has entered into an agreement with Mercury Medical for exclusive distribution of the FDA-cleared device SAFIRA (SAFer Injection for Regional Anesthesia) across the whole of the United States. Read more
Regional anaesthesia device to be demonstrated at Arab Health
A UK technology that aims to transform regional anaesthesia into a single operator procedure and improve patient safety, will be demonstrated live by a clinician in the field of anaesthesia at Arab Health 2022. Read more